Amyloid-like p53 as prognostic biomarker in serous ovarian cancer—a study of the OVCAD consortium

TP53 is the most commonly mutated gene in cancer and has been shown to form amyloid-like aggregates, similar to key proteins in neurodegenerative diseases. Nonetheless, the clinical implications of p53 aggregation remain unclear. Here, we investigated the presence and clinical relevance of p53 aggre...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Oncogene Ročník 42; číslo 33; s. 2473 - 2484
Hlavní autori:	Heinzl, Nicole, Maritschnegg, Elisabeth, Koziel, Katarzyna, Schilhart-Wallisch, Christine, Heinze, Georg, Yang, Wei-Lei, Bast, Robert C., Sehouli, Jalid, Braicu, Elena I., Vergote, Ignace, Van Gorp, Toon, Mahner, Sven, Paspalj, Valentina, Grimm, Christoph, Obermayr, Eva, Schuster, Eva, Holzer, Barbara, Rousseau, Frederic, Schymkowitz, Joost, Concin, Nicole, Zeillinger, Robert
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London Nature Publishing Group UK 11.08.2023 Nature Publishing Group
Predmet:	13/1 13/2 13/51 14 14/63 45/29 631/67/1517/1709 692/53/2422 82 Amyloid Apoptosis Autoantibodies Cell Biology Cytotoxicity Human Genetics Immune response Internal Medicine Medical prognosis Medicine Medicine & Public Health Missense mutation Neurodegenerative diseases Oncology Ovarian cancer p53 Protein Survival
ISSN:	0950-9232, 1476-5594, 1476-5594
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!